Dr. Lipton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Russo Building
1300 Morris Park Ave. Ste. 3
Bronx, NY 10461Phone+1 718-430-3886
Summary
- I am a board certified academic neurologist. My clinical practice is focused on headache medicine. My research focuses on headache medicine, cognitive aging and dementia. After attending the University of Chicago Pritzker School of Medicine, I completed a neurology residency at Einstein, fellowships in clinical neurophysiology (at Einstein) and neuroepidemiology (at Columbia) and have been Einstein faculty ever since. I am currently the Edwin S. Lowe Professor of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behavioral Sciences at Einstein. I conduct longitudinal epidemiological studies and clinical trials funded by the NIH, the FDA and industry.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1981 - 1986
- Northwestern UniversityMD, Medical internship, 1980 - 1981
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
- U of IllinoisBS, Biology, 1971 - 1975
- U of IllinoisBS, Biology, 1971 - 1975
Certifications & Licensure
- NY State Medical License 1983 - 2026
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Sleep Disordered Breathing and Subsequent Neuroimaging Markers of Brain Health in Hispanic/Latino Adults.Alberto R Ramos, Christian Agudelo, Kevin A Gonzalez, Wassim Tarraf, Martha Daviglus
Neurology. 2025-01-14 - Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial.Nicolai D Ayasse, Walter F Stewart, Richard B Lipton, David Gomez-Ulloa, M Chris Runken
Current Alzheimer Research. 2025-01-01 - Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-bl...Christopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, Suzanne Christie, Cristina Tassorelli
Cephalalgia. 2024-12-01
Press Mentions
- Revolutionary Migraine Drug Delivers Relief from Day OneDecember 23rd, 2024
- Ubrogepant Taken Early May Improve Outcomes in MigraineSeptember 20th, 2024
- Ubrogepant Offers Early Relief for Migraine SufferersAugust 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: